- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cereno Scientific AB (CRNOSb)
Cereno Scientific AB stock price live, this page displays ST CRNOSb stock exchange data. View the CRNOSb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cereno Scientific AB real time stock price chart below.
What Is the Cereno Scientific AB Stock Price Today?
The Cereno Scientific AB stock price today is 4.72.
What Is the Stock Symbol for Cereno Scientific AB?
The stock symbol for Cereno Scientific AB is "CRNOSb."
What Stock Exchange Does Cereno Scientific AB Trade On?
Cereno Scientific AB is listed and trades on the Stockholm stock exchange.
Is Cereno Scientific AB a Good Stock to Buy?
Determining whether Cereno Scientific AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRNOSb quote. (ISIN: SE0008241558)
What Is the Cereno Scientific AB Stock Price Today?
The Cereno Scientific AB stock price today is 4.72.
What Is the Stock Symbol for Cereno Scientific AB?
The stock symbol for Cereno Scientific AB is "CRNOSb."
What Stock Exchange Does Cereno Scientific AB Trade On?
Cereno Scientific AB is listed and trades on the Stockholm stock exchange.
Is Cereno Scientific AB a Good Stock to Buy?
Determining whether Cereno Scientific AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRNOSb quote. (ISIN: SE0008241558)
4.72
-0.09(-1.83%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.70
4.81
52 wk Range
4.30
11.10
Earnings results expected in 8 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.704.81
52 wk Range
4.3011.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CRNOSb Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
20.00
Upside
+323.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.00
(+323.73% Upside)
Earnings
Latest Release
May 27, 2026
EPS / Forecast
-0.09 / -0.07
Revenue / Forecast
38.97M / --
Compare CRNOSb to Peers and Sector
Metrics to compare | CRNOSb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRNOSbPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.4x | −3.0x | −0.3x | |
PEG Ratio | 1.64 | −0.07 | 0.00 | |
Price/Book | 6.6x | 3.2x | 2.6x | |
Price / LTM Sales | 22.5x | 238.1x | 3.1x | |
Upside (Analyst Target) | 315.8% | 124.4% | 49.0% | |
Fair Value Upside | Unlock | −12.6% | 6.3% | Unlock |
Cereno Scientific AB (publ), a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden. The company’s lead drug candidate is CS1, a HDACi, proprietary reformulation of VPA that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inhibitor that acts as an epigenetic modulator for pathological vascular remodeling, fibrotic tissue remodeling, inflammatory processes, pulmonary arterial pressure, thrombotic mechanisms. Its drugs portfolio includes CS014, an epigenetic modulator that is in phase I clinical trial for the treatment of cardiovascular, pulmonary diseases, pulmonary hypertension, and idiopathic pulmonary fibrosis; and preclinical drug candidates comprises CS585, a selective prostacyclin (IP) receptor agonist for the treatment of rare thrombotic diseases. The company has a collaboration agreement with the University of Michigan for the preclinical development program of CS585 and CS014, are preclinical drug candidate for cardiovascular diseases; and Abbott for use of CardioMEMS HF System. Cereno Scientific AB (publ) was incorporated in 2012 and is headquartered in Gothenburg, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Cereno Scientific (CRNOSb) Stock Price Today?
The Cereno Scientific stock price today is 4.72 SEK.
What Stock Exchange Does Cereno Scientific Trade On?
Cereno Scientific is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Cereno Scientific?
The stock symbol for Cereno Scientific is "CRNOSb."
What Is the Cereno Scientific Market Cap?
As of today, Cereno Scientific market cap is 1.47B SEK.
What Is Cereno Scientific's Earnings Per Share (TTM)?
The Cereno Scientific EPS (TTM) is -0.40.
When Is the Next Cereno Scientific Earnings Date?
Cereno Scientific will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is CRNOSb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cereno Scientific Stock Split?
Cereno Scientific has split 0 times.
How Many Employees Does Cereno Scientific Have?
Cereno Scientific has 10 employees.
What is the current trading status of Cereno Scientific (CRNOSb)?
As of Aug 18, 2026, Cereno Scientific (CRNOSb) is trading at a price of 4.72 SEK, with a previous close of 4.81 SEK. The stock has fluctuated within a day range of 4.70 SEK to 4.81 SEK, while its 52-week range spans from 4.30 SEK to 11.10 SEK.
What Is Cereno Scientific (CRNOSb) Price Target According to Analysts?
The average 12-month price target for Cereno Scientific is 20.00 SEK, with a high estimate of 20 SEK and a low estimate of 20 SEK. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +323.73% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.